SMTL ID : 9d3e.1

Cryo-EM structure of CCR6 bound by SQA1 and OXM2

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

hetero-1-1-1-1-mer

Ligands

1 x CLR: CHOLESTEROL(Non-covalent)

CLR.1: 6 residues within 4Å: Chain A: I.111, I.145, K.186, C.189, L.190, W.193 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:I.111, A:I.145, A:W.193 Hydrogen bonds: A:K.186

1 x EBX: 4-[[3,4-bis(oxidanylidene)-2-[[(1~{R})-1-(4-propan-2-ylfuran-2-yl)propyl]amino]cyclobuten-1-yl]amino]-~{N},~{N}-dimethyl-3-oxidanyl-pyridine-2-carboxamide(Non-covalent)

EBX.2: 18 residues within 4Å: Chain A: V.88, T.91, F.92, Y.95, A.98, S.100, T.102, D.103, L.106, R.164, A.385, V.388, I.389, Y.449, G.453, K.455, F.456, Y.459 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:V.88, A:F.92, A:T.102, A:L.106, A:I.389, A:Y.449, A:Y.459, A:Y.459 Hydrogen bonds: A:S.100, A:S.100, A:D.103, A:R.164, A:K.455, A:K.455, A:F.456

1 x 01: N-{[(2R)-4-(bicyclo[1.1.1]pentan-1-yl)-5-oxomorpholin-2-yl]methyl}-1-[4-(trifluoromethyl)phenyl]cyclopropane-1-carboxamide

01.3: 14 residues within 4Å: Chain A: K.143, Y.146, A.147, F.150, N.151, I.199, T.203, L.236, L.240, F.244, I.401, N.404, M.405, L.407 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:F.150, A:I.199, A:L.236, A:L.240, A:L.240, A:N.404, A:L.407 Hydrogen bonds: A:N.151, A:N.404 pi-Stacking: A:F.244

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Wasilko, D.J. et al., Structural basis for CCR6 modulation by allosteric antagonists. Nat Commun (2024)

Release Date

2024-09-11

Peptides

Human CCR6: A
anti-BRIL Fab Heavy chain: B
anti-BRIL Fab Nanobody: C
anti-BRIL Fab Light chain: D

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
H

C
K

D
L

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Human CCR6

anti-BRIL Fab Heavy chain

anti-BRIL Fab Nanobody

anti-BRIL Fab Light chain

Related Entries With Identical Sequence